By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


R-Tech Ueno 

10F, Yamato Life Insurance Building
1-1-7 Uchisaiwaicho, Chiyoda-ku
Tokyo    100-0011  Japan
Phone: 81-3-3596-8011 Fax: 81-3-3596-8023


Company News
Sucampo (SCMP) Offers to Buy R-Tech Ueno for $278 Million 8/26/2015 7:12:28 AM
R-Tech Ueno: Announcement On Collaborative Development Of Therapeutic Agent For Cerebral Infarction Utilizing VAP-1 Inhibitor (RTU-009) With Autonomous University Of Barcelona And Vall d'Hebron Institute Of Research 6/8/2015 10:37:36 AM
R-Tech Ueno: Announcement On Completion Of The Phase I Single-Dose Clinical Trial for the Novel VAP-1 Inhibitor RTU-1096 5/26/2015 11:14:23 AM
R-Tech Ueno: Announcement On Collaborative Development Of Therapeutic Agent For Diabetic Retinopathy And Diabetic Macular Edema Utilizing VAP-1 Inhibitor (RTU-1096) With Hokkaido University 5/18/2015 10:35:22 AM
R-Tech Ueno, Sucampo (SCMP) Dissolve Unoprostone Pacts 5/7/2015 6:04:53 AM
R-Tech Ueno: Announcement On Acquisition Of The Right To Develop And Commercialize DE-105 From Santen Pharmaceutical 4/27/2015 10:54:10 AM
R-Tech Ueno: The End Of A Phase 3 Clinical Study And Preliminary Findings From A Phase 3 Of Unoprostone (Development Code UF-021) For Treatment Of Retinitis Pigmentosa 3/9/2015 11:33:12 AM
Sucampo Pharmaceuticals, Inc. (SCMP) To Return All Licenses For Unoprostone Isopropyl To R-Tech Ueno 3/9/2015 7:33:51 AM
R-Tech Ueno Received Orphan Drug Designation For Unoprostone Isopropyl (Development Code:UF-021) For The Treatment Of Retinitis Pigmentosa From MHLW 11/25/2014 8:45:52 AM
R-Tech Ueno: Lawsuit Claiming Infringement Of AMITIZA® Capsules Patents 11/13/2014 11:13:46 AM